Ask whether GLP-1 medications for weight loss are explicitly covered, whether prior authorization is required, and exactly what documentation your provider must submit
This is a minor point compared to the others, but it costs nothing to do correctly
Due to the fact that GLP-1 acting drugs such as dulaglutide, liraglutide, and semaglutide do not need dosage adjustments for patients with renal impairment, these medications are considered to be the most recommended choices for patients who have chronic kidney disease (Zheng et al
Read more here: WATCH the in-depth report below | Hanna Mordoh
Maintaining muscle mass while using GLP-1 medications is crucial for overall health and metabolic well-being
The key question researchers are exploring is whether the triple-action system provides better weight keeping compared to dual agonists